Paper39088302
Human gut microbiota-reactive DP8α Tregs prevent acute graft-versus-host disease in a CD73-dependent manner.
Godefroy E and 19 others. JCI Insight, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Human gut microbiota-reactive DP8α Tregs prevent acute graft-versus-host disease in a CD73-dependent manner. Papers, record 39088302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39088302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human gut microbiota-reactive DP8α Tregs prevent acute graft-versus-host disease in a CD73-dependent manner.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Gastrointestinal Microbiome | Major topic |
| 5'-Nucleotidase | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Female | |
| Male | |
| Middle Aged | |
| Adult | |
| GPI-Linked Proteins | |
| Transplantation, Homologous | |
| Young Adult | |
| Faecalibacterium prausnitzii | |
| Acute Disease |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23520507 | Graft-versus-host disease is enhanced by selective CD73 blockade in mice. | PLoS One | 2013 | https://conductscience.org/library/papers/23520507 | PubMed |
| 2 | 22084406 | Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. | J Exp Med | 2011 | https://conductscience.org/library/papers/22084406 | PubMed |
| 3 | 19464988 | Human T regulatory cell therapy: take a billion or so and call me in the morning. | Immunity | 2009 | https://conductscience.org/library/papers/19464988 | PubMed |
| 4 | 29981781 | Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29981781 | PubMed |
| 5 | 25928296 | Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease. | PLoS One | 2015 | https://conductscience.org/library/papers/25928296 | PubMed |
| 6 | 30383447 | Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. | FASEB J | 2019 | https://conductscience.org/library/papers/30383447 | PubMed |
| 7 | 38474346 | Adenosine in Intestinal Epithelial Barrier Function. | Cells | 2024 | https://conductscience.org/library/papers/38474346 | PubMed |
| 8 | 32353108 | Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. | Blood Adv | 2020 | https://conductscience.org/library/papers/32353108 | PubMed |
| 9 | 17989707 | Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. | Gene Ther | 2008 | https://conductscience.org/library/papers/17989707 | PubMed |
| 10 | 30787928 | Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction. | Front Immunol | 2019 | https://conductscience.org/library/papers/30787928 | PubMed |
| 11 | 33239790 | The gut microbiota is associated with immune cell dynamics in humans. | Nature | 2020 | https://conductscience.org/library/papers/33239790 | PubMed |
| 12 | 17502665 | Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. | J Exp Med | 2007 | https://conductscience.org/library/papers/17502665 | PubMed |
| 13 | 26541363 | Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. | Biol Blood Marrow Transplant | 2016 | https://conductscience.org/library/papers/26541363 | PubMed |
| 14 | 26386318 | International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. | Biol Blood Marrow Transplant | 2016 | https://conductscience.org/library/papers/26386318 | PubMed |
| 15 | 30286447 | The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials. | J Innate Immun | 2019 | https://conductscience.org/library/papers/30286447 | PubMed |
| 16 | 12925844 | CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. | Nat Med | 2003 | https://conductscience.org/library/papers/12925844 | PubMed |
| 17 | 32267023 | Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group. | Am J Hematol | 2020 | https://conductscience.org/library/papers/32267023 | PubMed |
| 18 | 28729148 | Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models. | Biol Blood Marrow Transplant | 2017 | https://conductscience.org/library/papers/28729148 | PubMed |
| 19 | 27461930 | Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. | Blood | 2016 | https://conductscience.org/library/papers/27461930 | PubMed |
| 20 | 31418827 | Therapeutic use of regulatory T cells for graft-versus-host disease. | Br J Haematol | 2019 | https://conductscience.org/library/papers/31418827 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42852060 | Microbiota-derived metabolites in hematopoietic regulation and disease: mechanisms, context, and therapeutic perspectives. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42852060 | PubMed |
| 42807830 | MaaT013 fecal microbiotherapy modulates key gastro-intestinal and immunological processes involved in GvHD pathogenesis in vitro and in vivo. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42807830 | PubMed |
| 42706160 | [The correlation between lymphocyte subsets before autologous hematopoietic stem cell transplantation and hematopoietic reconstruction and recurrence after transplantation in multiple myeloma]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | https://conductscience.org/library/papers/42706160 | PubMed |
| 42393838 | Intratumoral enrichment and suppressive activity of DP8α regulatory T cells in human colorectal cancer. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/42393838 | PubMed |
| 42366515 | Identification of human DP8α regulatory T cell sub-populations reactive to health-associated anti-inflammatory gut commensals. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42366515 | PubMed |
| 42164507 | Regulatory T cell dysfunction and exhaustion in uveitis: immunometabolic mechanisms, microenvironmental drivers, and emerging therapeutic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42164507 | PubMed |
| 41593640 | Deciphering the intratumor microbiota in malignant gastrointestinal tumors: multifaceted interplay and clinical implications. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41593640 | PubMed |
| 41208998 | The crosstalk between probiotics and T cell immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/41208998 | PubMed |
| 41172558 | Regulatory T cell approaches for graft-versus-host disease prevention. | Curr Opin Immunol | 2026 | https://conductscience.org/library/papers/41172558 | PubMed |
| 40429375 | Hematopoietic Stem Cell Transplantation: Recent Advances. | J Clin Med | 2025 | https://conductscience.org/library/papers/40429375 | PubMed |
| 39597645 | Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach. | Microorganisms | 2024 | https://conductscience.org/library/papers/39597645 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NT5E | 4907 | PubTator's text mining | https://conductscience.org/library/genes/4907 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39088302
GET https://conductscience.org/api/papers/v1/39088302/references?page=2